Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy

被引:75
|
作者
Bunch, T. Jared [1 ]
Munger, Thomas M. [1 ]
Friedman, Paul A. [1 ]
Asirvatham, Samuel J. [1 ]
Brady, Peter A. [1 ]
Cha, Yong-Mei [1 ]
Rea, Robert F. [1 ]
Shen, Win-Kuang [1 ]
Powell, Brian D. [1 ]
Ommen, Steve R. [1 ]
Monahan, Kristi H. [1 ]
Haroldson, Janis M. [1 ]
Packer, Douglas L. [1 ]
机构
[1] St Marys Hosp, Mayo Clin, Heart Rhythm Serv, Dept Internal Med,Div Cardiovasc Dis, Rochester, MN 55902 USA
关键词
catheter ablation; atrial fibrillation; hypertrophic cardiomyopathy; heart atrium; diastole;
D O I
10.1111/j.1540-8167.2008.01192.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Substrate and Procedural Predictors of Outcome in Patients with Hypertrophic Cardiomyopathy. Background: Hypertrophic cardiomyopathy (HCM) is often accompanied by atrial fibrillation (AF) due to diastolic dysfunction, elevated left atrial pressure, and enlargement. Although catheter ablation for drug-refractory AF is an effective treatment, the efficacy in HCM remains to be established. Methods: Thirty-three consecutive patients (25 male, age 51 +/- 11 years) with HCM underwent pulmonary vein (PV) isolation (n = 8) or wide area circumferential ablation with additional linear ablation (n = 25) for drug-refractory AF. Twelve-lead and 24-hour ambulating ECGs, echocardiograms, event monitor strips, and SF 36 quality of life (QOL) surveys were obtained before ablation and for routine follow-up. Results: Twenty-one (64%) patients had paroxysmal AF and 12 (36%) had persistent/permanent AF for 6.2 +/- 5.2 years. The average ejection fraction was 0.63 +/- 0.12. The average left atrial volume index was 70 +/- 24 mL/m(2). Over a follow-up of 1.5 +/- 1.2 years, 1-year survival with AF elimination was 62%(Confidence Interval [CI]: 66-84) and with AF control was 75%(CI: 66-84). AF control was less likely in patients with a persistent/chronic AF, larger left atrial volumes, and more advanced diastolic disease. Additional linear ablation may improve outcomes in patient with severe left atrial enlargement and more advanced diastolic dysfunction. Two patients had a periprocedureal TIA, one PV stenosis, and one died after mitral valve replacement from prosthetic valve thrombosis. QOL scores improved from baseline at 3 and 12 months. Conclusion: Outcomes after AF ablation in patients with HCM are favorable. Diastolic dysfunction, left atrial enlargement, and AF subtype influence outcomes. Future studies of rhythm management approaches in HCM patients are required to clarify the optimal clinical approach.
引用
收藏
页码:1009 / 1014
页数:6
相关论文
共 50 条
  • [1] Substrate predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy
    Bunch, T. J.
    Munger, Thomas M.
    Friedman, Paul A.
    Asirvatham, Samuel J.
    Brady, Peter A.
    Cha, Yong-Mei
    Rea, Robert F.
    Shen, Win-Kuang
    Monahan, Kristi M.
    Haroldson, Janis R.
    Packer, Douglas L.
    CIRCULATION, 2007, 116 (16) : 537 - 537
  • [2] OUTCOMES OF CATHETER ABLATION FOR ATRIAL FIBRILLATION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
    Garg, Lohit
    Sabzwari, Syed Rafay Ali
    Akbar, Ghulam
    Ayele, Hiwot
    Agrawal, Sahil
    Agarwal, Manyoo
    Gordon, Jeffrey
    Dusaj, Raman
    Nazir, Talha
    Bozorgnia, Babak
    Martinez, Matthew
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 478 - 478
  • [3] Outcomes of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
    Agarwal, Siddharth
    Munir, Muhammad Bilal
    Patel, Harsh
    Desimone, Christopher, V
    Deshmukh, Abhishek
    Asad, Zain Ul Abideen
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 207 : 1 - 3
  • [4] Catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy
    Prutkin, Jordan M.
    Owens, David S.
    HEART, 2016, 102 (19) : 1513 - 1514
  • [5] Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy
    Yan, Q.
    Dong, J. Z.
    Long, D. Y.
    Yu, R. H.
    Tang, R. B.
    Du, X.
    Bai, R.
    Ma, C. S.
    EUROPEAN HEART JOURNAL, 2013, 34 : 102 - 102
  • [6] Five-year outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy
    Zheng, Shunwen
    Jiang, Weifeng
    Dai, Jinjie
    Li, Kaige
    Shi, Hongyu
    Wu, Weihua
    Liu, Xu
    He, Ben
    Qiu, Xingbiao
    Song, Zhiping
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2020, 31 (03) : 621 - 628
  • [7] Outcomes of Catheter Ablation of Atrial Fibrillation in Hypertrophic Cardiomyopathy Patients - A Pooled Analysis
    Yarlagadda, Vivek
    Kanmanthareddy, Arun
    Dherange, Parinita A.
    Agasthi, Pradyumna
    Sridhar, Arun Raghav Mahankhali
    Bommana, Sudharani
    Atkins, Donita
    Natale, Andrea
    Di Biase, Luigi
    Lakkireddy, Dhanunjaya
    Reddy, Madhu
    CIRCULATION, 2015, 132
  • [8] Left atrial wall thickness and outcomes of catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy
    Hayashi, Hiroshi
    Hayashi, Meiso
    Miyauchi, Yasushi
    Takahashi, Kenta
    Uetake, Shunsuke
    Tsuboi, Ippei
    Yodogawa, Kenji
    Iwasaki, Yu-Ki
    Shimizu, Wataru
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2014, 40 (02) : 153 - 160
  • [9] Left atrial wall thickness and outcomes of catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy
    Hiroshi Hayashi
    Meiso Hayashi
    Yasushi Miyauchi
    Kenta Takahashi
    Shunsuke Uetake
    Ippei Tsuboi
    Kenji Yodogawa
    Yu-Ki Iwasaki
    Wataru Shimizu
    Journal of Interventional Cardiac Electrophysiology, 2014, 40 : 153 - 160
  • [10] Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy patients: a systematic review
    Ha, Hakeem S. K.
    Wang, Nelson
    Wong, Sophia
    Phan, Steven
    Liao, Jace
    Kumar, Narendra
    Qian, Pierre
    Yan, Tristan D.
    Phan, Kevin
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2015, 44 (02) : 161 - 170